Piotr J. Wysocki
Jagiellonian University(PL)Lodz University of Technology(PL)Krakow Cardiovascular Research Institute(PL)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Immunotherapy and Immune Responses, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial(2022)235 cited
- → BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)—Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd).(2021)106 cited
- → Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin(2010)73 cited
- → mTOR in renal cell cancer: modulator of tumor biology and therapeutic target(2009)64 cited
- → Abstract CT014: IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)(2020)62 cited
- → Targeted therapy of hepatocellular cancer(2010)